A. Camagna et al., ERYTHROCYTE UROPORPHYRINOGEN DECARBOXYLASE ACTIVITY - DIAGNOSTIC-VALUE AND RELATIONSHIP WITH CLINICAL-FEATURES IN HEREDITARY PORPHYRIA-CUTANEA-TARDA, The American journal of the medical sciences, 315(1), 1998, pp. 59-62
A marked discrepancy between mild and late clinical features and a nea
rly complete absence of erythrocyte uroporphyrinogen decarboxylase act
ivity (Ery-UROD activity) was observed in a case of inherited porphyri
a cutanea tarda. The entity and time of appearance of clinical feature
s, the onset of clinical symptoms after exposure to contributing facto
rs, the effectiveness of phlebotomies and heterozygosity of the mother
alone for uroporphyrinogen decarboxylase (UROD) deficiency were typic
al for familial porphyria cutanea tarda (F-PCT), whereas the extremely
low UROD activity was peculiar to hepatoerythropoietic porphyria (HEP
). These observations indicate that: 1) Ery-UROD activity may not alwa
ys be useful to discriminate between F-PCT and HEP; 2) Ery-UROD activi
ty does not always correlate with clinical symptoms; 3) in inherited U
ROD deficiency, the genetic defect may be heterogeneous. Finally, the
observed discrepancy may provide additional evidence for the existence
of tissue-specific isozymes.